Evelo Biosciences Inc
General ticker "EVLO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $8.7K
Evelo Biosciences Inc does not follow the US Stock Market performance with the rate: -40.6%.
Estimated limits based on current volatility of 6.1%: low 0.00$, high 0.00$
Factors to consider:
- Earnings expected soon, date: nan
- Current price 100.0% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [9.48$, 36.48$]
- 2023-12-31 to 2024-12-30 estimated range: [4.05$, 16.14$]
Financial Metrics affecting the EVLO estimates:
- Negative: Non-GAAP EPS, $ of -29.00 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -38.37 <= 2.35
- Negative: negative Net income
- Negative: Interest expense per share, $ of 1.07 > 0.74
- Negative: Industry operating cash flow per share per price (median), % of -21.66 <= 3.85
- Negative: Inventory ratio change, % of 100 > 1.08
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: -0.96 < Investing cash flow per share, $ of -0.14
Short-term EVLO quotes
Long-term EVLO plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $91.89MM | $115.40MM | $108.47MM |
| Operating Income | $-91.89MM | $-115.40MM | $-108.47MM |
| Non-Operating Income | $-1.37MM | $-6.35MM | $-5.13MM |
| Interest Expense | $2.11MM | $3.61MM | $4.67MM |
| R&D Expense | $69.62MM | $83.64MM | $78.55MM |
| Income(Loss) | $-93.26MM | $-121.75MM | $-113.60MM |
| Taxes | $0.41MM | $0.43MM | $0.93MM |
| Profit(Loss) | $-93.67MM | $-122.18MM | $-114.53MM |
| Stockholders Equity | $30.48MM | $8.67MM | $-4.99MM |
| Assets | $90.64MM | $87.87MM | $64.44MM |
| Operating Cash Flow | $-73.06MM | $-96.72MM | $-101.23MM |
| Capital expenditure | $1.32MM | $1.52MM | $0.62MM |
| Investing Cash Flow | $-1.31MM | $-1.48MM | $-0.62MM |
| Financing Cash Flow | $65.47MM | $97.54MM | $81.66MM |
| Earnings Per Share* | $-47.45 | $-46.18 | $-26.28 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.